« Back
Home /
COVID-19 Vaccinated Granulocytes

COVID-19 Vaccinated Granulocytes

Item no.	CoV-Vac-Granulocyte
Manufacturer	Raybiotech
Amount	Granulocyte layer from 50 cc of whole blood (1 patient)
Category	Cell Lines & Cell Culture Cell Lines
Type	Cells
Format	Frozen with 10% DMSO
Specific against	Human (Homo sapiens)
Dry ice	Yes
ECLASS 10.1	32160890
ECLASS 11.0	32160890
UNSPSC	41106509
Shipping Condition	Dry ice
Available
Manufacturer - Category	COVID-19\|Biospecimen Samples
Shipping Temperature	Dry ice (additional shipping fee)
Storage Conditions	-70°C
Compatible Sample Types	Granulocytes (treated with red blood cell lysis buffer)
UNSPSC Code	41116012
Format	Frozen with 10% DMSO
Restrictions	For USA only
Anticoagulant	EDTA
Biosafety Level	2 Note: These samples have not been tested for the presence of any pathogens and should be assumed infectious.
Background	During Ficoll density gradient centrifugation, granulocytes (neutrophils, basophils, eosinophils) form a layer separate from peripheral blood mononuclear cells (PBMCs). The granulocyte layer is directly above the red blood cells. Thus, when this layer is collected, red blood cells will be present. After isolating this layer, RayBiotech will lyse the red blood cells. The number of granulocytes obtained per patient will vary. All cells will be provided to customer the number of provided cells cannot be guaranteed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CoV-Vac-Granulocyte-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: Granulocyte layer from 50 cc of whole blood (1 patient)

not available